Inefficient Vaginal Transmission of Tenofovir-Resistant HIV-1

Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention

(2012) Ariane van der Straten et al.   AIDS

Antiviral agents and HIV prevention

(2012) Myron S. Cohen et al.   AIDS

Preexposure Prophylaxis for HIV — Where Do We Go from Here?

(2012) Myron S. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana

(2012) Michael C. Thigpen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

(2012) Jared M. Baeten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preexposure Prophylaxis for HIV Infection among African Women

(2012) Lut Van Damme et al.   NEW ENGLAND JOURNAL OF MEDICINE

Factors limiting the transmission of HIV mutations conferring drug resistance: fitness costs and genetic bottlenecks

(2012) Bradley G. Wagner et al.   Scientific Reports

Pre-Exposure Prophylaxis and Antiretroviral Resistance: HIV Prevention at a Cost?

(2011) C. B. Hurt et al.   CLINICAL INFECTIOUS DISEASES

Transmission dynamics of the M184V drug resistance mutation in primary HIV infection

(2011) M. A. Wainberg et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Detection of Low-Level K65R Variants in Nucleoside Reverse Transcriptase Inhibitor–Naive Chronic and Acute HIV-1 Subtype C Infections

(2011) Jin-fen Li et al.   JOURNAL OF INFECTIOUS DISEASES

Loss of Neuronal Integrity during Progressive HIV-1 Infection of Humanized Mice

(2011) P. K. Dash et al.   JOURNAL OF NEUROSCIENCE

Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection

(2011) Rikke Olesen et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates

(2011) P. W. Denton et al.   JOURNAL OF VIROLOGY

Prevention of HIV-1 Infection with Early Antiretroviral Therapy

(2011) Myron S. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques

(2011) Mian-er Cong et al.   VIROLOGY

Reverse transcriptase mutation K65N confers a decreased replication capacity to HIV-1 in comparison to K65R due to a decreased RT processivity

(2011) HimaBindu Chunduri et al.   VIROLOGY

Implications of HIV PrEP Trials Results

(2010) Fulvia Veronese et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Transmitted HIV-1 Drug Resistance Among Young Men of Color Who Have Sex With Men: A Multicenter Cohort Analysis

(2010) Lisa B. Hightow-Weidman et al.   JOURNAL OF ADOLESCENT HEALTH

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

(2010) Q. Abdool Karim et al.   SCIENCE

Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/γc−/−, Balb/c-Rag1−/−γc−/−, and C.B-17-scid/bg immunodeficient mice

(2009) Christin M. Lepus et al.   HUMAN IMMUNOLOGY

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

(2009) Diane E. Bennett et al.   PLoS One

Transmission networks of drug resistance acquired in primary/early stage HIV infection

(2008) Bluma G Brenner et al.   AIDS

The prevalence of transmitted antiretroviral drug resistance in treatment-naïve patients and factors influencing first-line treatment regimen selection

(2008) H-Y Huang et al.   HIV MEDICINE

Preexisting Resistance to Nonnucleoside Reverse‐Transcriptase Inhibitors Predicts Virologic Failure of an Efavirenz‐Based Regimen in Treatment‐Naive HIV‐1–Infected Subjects

(2008) Daniel R. Kuritzkes et al.   JOURNAL OF INFECTIOUS DISEASES